Windlas Biotech Ltd. IPO

It is among the top 5 companies in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO) industry.

RHP
View
DRHP
View
Open Date

2021-08-04

Close Date

2021-08-06

Windlas Biotech Ltd. IPO Details

Check out the issue details for Windlas Biotech Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 460

Price Band

₹ 448 - 460

Issue Size

401.53 Cr.

Issue Type

Book Built

Open

2021-08-04

Close

2021-08-06

Listingprice

₹ 437

ListingGain

-5.00%

Listing Date

2021-08-16

CMP

₹ 961.7

Current Return

109.07%

Company Financials

You can get the following financial statements of Windlas Biotech Ltd. as of now.

The valuation of Windlas Biotech IPO company based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 460
Existing Shares (Qty) 1.82 Cr
Fresh Issue (Qty)  0.36 Cr
Market Cap ~1003 Cr
EPS  Rs 8.7 
PE Ratio ~53x
Industry PE ~13x

 

Windlas Biotech IPO issue size is 401.54 Cr

Issue Amount
Fresh Issue 165 Cr
Offer For Sale 236.54 Cr

 

An Individual can apply for a minimum 1 lot of 30 shares and a maximum of 14 lots of 420 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 30 Rs 13,800
 Maximum 14 420 Rs 1,93,200

 

Windlas Biotech IPO is subscribed 22.44 times till 6th August. It is Oversubscribed as of now. The category-wise subscription is as follows:

Category % Offered Subscription 
Qualified Institutional Maximum 50% 24.40 Times
Non-Institutional Minimum 15% 15.73 Times
Retail Individual Minimum 35% 24.22 Times
Total   22.44 Times

Once you have subscribed to an IPO, you have to wait for its allotment to your account. Find below the dates of allotment of Windlas Biotech IPO:

Schedule Date
Basis of Allotment 11 August 2021
Refunds 12 August 2021
Credit to Demat Account 13 August 2021
IPO Listing Date 16 August 2021

 

When the allotment is out, you can check it from the registrar's website. Find the Windlas Biotech IPO allotment status here.

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 328.85 427.6 465.93 513.08 630.96
Total Expenditure 287.39 372.91 413.04 452.84 552.85
Operating Profit 41.47 54.69 52.9 60.24 78.1
Other Income 2.49 3.09 6.71 9.97 13.47
Interest 2.53 1.29 1.42 0.79 1.1
Depreciation 9.29 12.97 12.15 12.36 13.44
Exceptional Items 0 -32.35 0 0 0
Profit Before Tax 32.13 11.18 46.04 57.06 77.02
Provision for Tax 8.46 6.17 7.48 14.41 18.88
Net Profit 23.68 5.01 38.56 42.64 58.14
Adjusted EPS (Rs.) 1.3 0.28 1.77 2.04 2.8

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 6.41 6.41 10.9 10.46 10.4
Total Reserves 213.94 192.58 384.23 392.2 439.89
Borrowings 1.21 0.83 0.44 0.11 0
Other N/C liabilities 1.66 2.75 -0.23 3.33 3.95
Current liabilities 125.29 93.42 93.65 120.88 171.35
Total Liabilities 348.52 295.99 488.99 526.98 625.59
Assets
Net Block 70.26 95.94 91.18 109.41 179.05
Capital WIP 0 0.04 7.58 13.8 5.71
Intangible WIP 0 0 0.43 0.98 0
Investments 104.69 0.03 0.03 0.03 0
Loans & Advances 5.4 5.84 5.39 43.31 7.54
Other N/C Assets 0.13 0 2.73 5.92 2.05
Current Assets 168.03 194.15 381.63 353.54 431.24
Total Assets 348.52 295.99 488.99 526.98 625.59
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Other Income 3.24 3.16 4.44 4.13 4.84
Profit Before Tax 18.31 19.81 22.56 18.31 20.29
Tax 4.28 4.71 5.61 4.83 4.63
Profit After Tax 14.03 15.1 16.95 13.48 15.66
Adjusted EPS (Rs) 6.75 7.26 8.15 6.45 7.49

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 62.51 0
Jun 2024 62.51 0
Mar 2024 62.82 0
Dec 2023 62.82 0
Sep 2023 62.82 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 32.13 11.18 46.04 57.06 77.02
Adjustment 9.77 46.85 9.75 7.35 6.6
Changes in Assets & Liabilities -3.53 -40.05 -37.91 6.29 43.91
Tax Paid -13.46 -6.53 -8.88 -9.72 -18.62
Operating Cash Flow 24.91 11.45 9 60.98 108.91
Investing Cash Flow -14.25 -14.53 -154.31 -14.11 -92.07
Financing Cash Flow -5.44 0.78 130.09 -43.74 -15.29
Net Cash Flow 5.22 -2.3 -15.22 3.13 1.56
X